Korecyte Bio presented its ambitions for CAR-T against solid tumours during the LSX Investival conference in London in November 2024. The Investival Showcase had been organised by LSX Ltd and partnered with Jefferies LLC.
This website uses cookies to ensure that you have the best experience. If you continue to use this site we will assume that you agree to this.